iSelect Fund invests in early-stage, high-growth companies primarily in the Midwest, focusing on agriculture, food, health, and technology sectors. Their strategy emphasizes identifying ventures that solve real-world problems and generate both financial returns and positive impact.
38% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-a (50% of deals). Average disclosed round size is $33.1M (across 16 rounds with reported amounts).
Portfolio
16
Fund Size
$147M
Top Stage
Series A
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
16 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| MMiraterra | Series A | $16M | Mar 2026 |
 Mercy BioAnalytics, Inc. | Series B | $59M | Sep 2025 |
 Edacious | Seed | $8.1M | Feb 2025 |
 One Bio | Series A | $27M | Dec 2024 |
 Mend Nutrition Inc. | Series A | $15M | Jun 2023 |
 Pluton Biosciences | Series A | $16.5M | May 2023 |
 EarthOptics | Series B | $27.6M | Jan 2023 |
| AAgriWebb | Series B | $6.8M | Oct 2022 |
 Bond Pet Foods | Series A | $17.5M | Sep 2022 |
| Bond Pet Foods | Series A | $17.5M | Jun 2022 |
 Molecular Assemblies Inc. | Series B | $25.8M | Mar 2022 |
 Sentera, LLC | Series C | $25M | Jun 2021 |
 Benson Hill | Series D | $150M | Oct 2020 |
 Geltor | Series B | $91.3M | Jul 2020 |
 Artemis | Series A | $8M | May 2019 |
 Cofactor Genomics | Series A | $18M | Sep 2017 |
Top Co-Investors
S2G Ventures5 shared
Cavallo Ventures2 shared
Leaps by Bayer2 shared
Argonautic Ventures2 shared
CDPQ2 shared
Fall Line Capital2 shared
Lever VC1 shared
Route 66 Ventures1 shared
Astanor1 shared
Talis Capital1 shared
CPT Capital1 shared
WTT Investment Ltd.1 shared
Cultivian Sandbox1 shared
SOSV1 shared
Blue Horizon1 shared
RIT Capital Partners1 shared
Humboldt Fund1 shared
Pegasus Tech Ventures1 shared
Alpha Edison1 shared
Morado Ventures1 shared
Last updated: 15 April 2026